Compare MBIN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBIN | QDEL |
|---|---|---|
| Founded | 1990 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | 2022 |
| Metric | MBIN | QDEL |
|---|---|---|
| Price | $41.76 | $17.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $43.67 | $32.75 |
| AVG Volume (30 Days) | 241.4K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $31.76 | $3.51 |
| Revenue Next Year | $3.73 | $3.86 |
| P/E Ratio | $12.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.25 | $17.37 |
| 52 Week High | $48.50 | $37.24 |
| Indicator | MBIN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 23.00 |
| Support Level | $30.89 | N/A |
| Resistance Level | $48.50 | $30.65 |
| Average True Range (ATR) | 1.38 | 1.15 |
| MACD | -0.44 | -0.27 |
| Stochastic Oscillator | 37.71 | 0.68 |
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.